EYPT vs STZ · rev $1.2M vs P/E 14, rev $9.14B
Eyepoint Pharmaceuticals Inc (EYPT) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
EYPT currently screens at market cap $1.10B. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the EYPT and STZ stock pages for the full models.
Not investment advice.